Investing Acceleration of RAD204 Phase 1 dose escalation trial by admin May 12, 2025 May 12, 2025 Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com previous post Triumph Gold Discovers a New Silver and Gold Vein Showing at the Freegold Mountain Project, Yukon next post House GOP unveils Medicaid work requirements in Trump’s ‘big, beautiful bill’ You may also like NVIDIA Eyeing US$100 Million Investment in OpenAI’s US$100... September 3, 2024 RETRANSMISSION: Group Eleven to be Featured on Radius... May 9, 2025 Phase 1 Drill Program – Operational and Geological... May 28, 2025 Cygnus raises $18.3m to accelerate resource growth and... June 20, 2025 Brunswick Exploration Outlines Significant New Lithium Potential in... October 17, 2024 Firm Commitments Received for ~$1.5M Placement July 29, 2024 West High YieldResources Ltd. Announces Private Placement Offering,... February 21, 2025 Osisko Intersects 330.6 Metres Averaging 0.46% Cu in... November 12, 2025 IDM and Blackstone Confirm Rich Copper-Gold Zone at... May 1, 2025 Quetzal Copper Mobilizes for Maiden Drill Program at... January 16, 2025